IP3RPEP6, a novel peptide inhibitor of IP
Ca2+ signaling
IP3
astrocytes
connexin-43
hemichannel
inositol 1,4,5-trisphosphate
peptide inhibitor
Journal
Acta physiologica (Oxford, England)
ISSN: 1748-1716
Titre abrégé: Acta Physiol (Oxf)
Pays: England
ID NLM: 101262545
Informations de publication
Date de publication:
19 Jan 2024
19 Jan 2024
Historique:
revised:
24
10
2023
received:
20
07
2023
accepted:
01
01
2024
medline:
19
1
2024
pubmed:
19
1
2024
entrez:
19
1
2024
Statut:
aheadofprint
Résumé
Inositol 1,4,5-trisphosphate receptors (IP IP3RPEP6 was developed by in silico molecular docking studies and characterized by on-nucleus patch-clamp experiments of IP IP3RPEP6 concentration-dependently reduced the open probability of IP IP3RPEP6 inhibits IP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14086Subventions
Organisme : China Scholarship Council
ID : 201906170050
Organisme : Onderzoeksraad, KU Leuven
ID : C14/19/099
Organisme : Onderzoeksraad, KU Leuven
ID : AKUL/19/34
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G052718N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G040720N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G063023N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G090118N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G0E7520N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G081821N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G094522N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : W0.019.17N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : W0.014.22N
Informations de copyright
© 2024 The Authors. Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society.
Références
Foskett JK, White C, Cheung KH, Mak DOD. Inositol trisphosphate receptor Ca2+ release channels. Physiol Rev. 2007;87(2):593-658.
Hamada K, Mikoshiba K. IP(3) receptor plasticity underlying diverse functions. Annu Rev Physiol. 2020;82:151-176.
Berridge MJ. The inositol trisphosphate/calcium signaling pathway in health and disease. Physiol Rev. 2016;96(4):1261-1296.
Garcia MI, Boehning D. Cardiac inositol 1,4,5-trisphosphate receptors. Biochim Biophys Acta Mol Cell Res. 2017;1864(6):907-914.
Parys JB, De Smedt H. Inositol 1,4,5-trisphosphate and its receptors. Adv Exp Med Biol. 2012;740:255-279.
Gambardella J, Lombardi A, Morelli MB, Ferrara J, Santulli G. Inositol 1,4,5-trisphosphate receptors in human disease: a comprehensive update. J Clin Med. 2020;9(4):1096.
Ivanova H, Vervliet T, Missiaen L, Parys JB, De Smedt H, Bultynck G. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival. Biochim Biophys Acta. 2014;1843(10):2164-2183.
Bartok A, Weaver D, Golenár T, et al. IP(3) receptor isoforms differently regulate ER-mitochondrial contacts and local calcium transfer. Nat Commun. 2019;10(1):3726.
Serysheva II, Baker MR, Fan G. Structural insights into IP(3)R function. Adv Exp Med Biol. 2017;981:121-147.
Fan G, Baker ML, Wang Z, et al. Gating machinery of InsP3R channels revealed by electron cryomicroscopy. Nature. 2015;527(7578):336-341.
Hamada K, Miyatake H, Terauchi A, Mikoshiba K. IP(3)-mediated gating mechanism of the IP(3) receptor revealed by mutagenesis and X-ray crystallography. Proc Natl Acad Sci U S A. 2017;114(18):4661-4666.
Kang M, Lin N, Li C, et al. Cx43 phosphorylation on S279/282 and intercellular communication are regulated by IP3/IP3 receptor signaling. Cell Commun Signal. 2014;12:58.
Michelangeli F, Mezna M, Tovey S, Sayers LG. Pharmacological modulators of the inositol 1,4,5-trisphosphate receptor. Neuropharmacology. 1995;34(9):1111-1122.
Ghosh TK, Eis PS, Mullaney JM, Ebert CL, Gill DL. Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin. J Biol Chem. 1988;263(23):11075-11079.
Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K. 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of ins(1,4,5)P3-induced Ca2+ release. J Biochem. 1997;122(3):498-505.
Parker I, Ivorra I. Caffeine inhibits inositol trisphosphate-mediated liberation of intracellular calcium in Xenopus oocytes. J Physiol. 1991;433:229-240.
Gafni J, Munsch JA, Lam TH, et al. Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron. 1997;19(3):723-733.
Gambardella J, Morelli MB, Wang X, Castellanos V, Mone P, Santulli G. The discovery and development of IP3 receptor modulators: an update. Expert Opin Drug Discov. 2021;16(6):709-718.
Bultynck G, Sienaert I, Parys JB, et al. Pharmacology of inositol trisphosphate receptors. Pflugers Arch. 2003;445(6):629-642.
Ivanova H, Wagner LE 2nd, Tanimura A, et al. Bcl-2 and IP(3) compete for the ligand-binding domain of IP(3)Rs modulating Ca(2+) signaling output. Cell Mol Life Sci. 2019;76(19):3843-3859.
Azumaya CM, Linton EA, Risener CJ, Nakagawa T, Karakas E. Cryo-EM structure of human type-3 inositol triphosphate receptor reveals the presence of a self-binding peptide that acts as an antagonist. J Biol Chem. 2020;295(6):1743-1753.
Leybaert L, Sanderson MJ. Intercellular Ca(2+) waves: mechanisms and function. Physiol Rev. 2012;92(3):1359-1392.
Bezprozvanny I, Watras J, Ehrlich BE. Bell-shaped calcium-response curves of ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature. 1991;351(6329):751-754.
Keizer J, De Young GW. Two roles of Ca2+ in agonist stimulated Ca2+ oscillations. Biophys J. 1992;61(3):649-660.
Goldbeter A, Dupont G, Berridge MJ. Minimal model for signal-induced Ca2+ oscillations and for their frequency encoding through protein phosphorylation. Proc Natl Acad Sci U S A. 1990;87(4):1461-1465.
De Bock M, Wang N, Bol M, et al. Connexin 43 hemichannels contribute to cytoplasmic Ca2+ oscillations by providing a bimodal Ca2+−dependent Ca2+ entry pathway. J Biol Chem. 2012;287(15):12250-12266.
Bol M, Wang N, De Bock M, et al. At the cross-point of connexins, calcium, and ATP: blocking hemichannels inhibits vasoconstriction of rat small mesenteric arteries. Cardiovasc Res. 2017;113(2):195-206.
De Bock M, Culot M, Wang N, et al. Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability. J Cereb Blood Flow Metab. 2011;31(9):1942-1957.
Turovsky EA, Varlamova EG, Turovskaya MV. Activation of Cx43 hemichannels induces the generation of Ca(2+) oscillations in white adipocytes and stimulates lipolysis. Int J Mol Sci. 2021;22(15):8095.
De Bock M, Wang N, Decrock E, et al. Endothelial calcium dynamics, connexin channels and blood-brain barrier function. Prog Neurobiol. 2013;108:1-20.
Braet K, Vandamme W, Martin PEM, Evans WH, Leybaert L. Photoliberating inositol-1,4,5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap 26. Cell Calcium. 2003;33(1):37-48.
De Smet MA, Lissoni A, Nezlobinsky T, et al. Cx43 hemichannel microdomain signaling at the intercalated disc enhances cardiac excitability. J Clin Invest. 2021;131(7):e137752.
Srinivas M, Calderon DP, Kronengold J, Verselis VK. Regulation of connexin hemichannels by monovalent cations. J Gen Physiol. 2006;127(1):67-75.
Li F, Sugishita K, Su Z, Ueda I, Barry WH. Activation of connexin-43 hemichannels can elevate [Ca(2+)]i and [Na(+)]i in rabbit ventricular myocytes during metabolic inhibition. J Mol Cell Cardiol. 2001;33(12):2145-2155.
John SA, Kondo R, Wang SY, Goldhaber JI, Weiss JN. Connexin-43 hemichannels opened by metabolic inhibition. J Biol Chem. 1999;274(1):236-240.
Kondo RP, Wang SY, John SA, Weiss JN, Goldhaber JI. Metabolic inhibition activates a non-selective current through connexin hemichannels in isolated ventricular myocytes. J Mol Cell Cardiol. 2000;32(10):1859-1872.
Eltzschig HK, Eckle T, Mager A, et al. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res. 2006;99(10):1100-1108.
Kang J, Kang N, Lovatt D, et al. Connexin 43 hemichannels are permeable to ATP. J Neurosci. 2008;28(18):4702-4711.
Gossman DG, Zhao H-B. Hemichannel-mediated inositol 1,4,5-trisphosphate (IP3) release in the cochlea: a novel mechanism of IP3 intercellular signaling. Cell Commun Adhes. 2008;15(4):305-315.
Saladin A, Rey J, Thévenet P, Zacharias M, Moroy G, Tufféry P. PEP-SiteFinder: a tool for the blind identification of peptide binding sites on protein surfaces. Nucleic Acids Res. 2014;42:W221-W226.
Lamiable A, Thévenet P, Eustache S, Saladin A, Moroy G, Tuffery P. Peptide suboptimal conformation sampling for the prediction of protein-peptide interactions. Methods Mol Biol. 2017;1561:21-34.
Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics. 2016;54:5.6.1-5.6.37.
Wagner LE 2nd, Yule DI. Differential regulation of the InsP₃ receptor type-1 and -2 single channel properties by InsP₃, Ca2+ and ATP. J Physiol. 2012;590(14):3245-3259.
Alzayady KJ, Wagner LE 2nd, Chandrasekhar R, et al. Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits. J Biol Chem. 2013;288(41):29772-29784.
Atakpa P, Thillaiappan NB, Mataragka S, Prole DL, Taylor CW. IP(3) receptors preferentially associate with ER-lysosome contact sites and selectively deliver Ca(2+) to lysosomes. Cell Rep. 2018;25(11):3180-3193.e7.
Alzayady KJ, Wang L, Chandrasekhar R, Wagner LE 2nd, Van Petegem F, Yule DI. Defining the stoichiometry of inositol 1,4,5-trisphosphate binding required to initiate Ca2+ release. Sci Signal. 2016;9(422):ra35.
Decrock E, De Bock M, Wang N, Bol M, Gadicherla AK, Leybaert L. Electroporation loading and flash photolysis to investigate intra- and intercellular Ca2+ signaling. Cold Spring Harb Protoc. 2015;2015(3):239-249.
Decrock E, De Vuyst E, Vinken M, et al. Connexin 43 hemichannels contribute to the propagation of apoptotic cell death in a rat C6 glioma cell model. Cell Death Differ. 2009;16(1):151-163.
De Vuyst E, De Bock M, Decrock E, et al. In situ bipolar electroporation for localized cell loading with reporter dyes and investigating gap junctional coupling. Biophys J. 2008;94(2):469-479.
Jiang D, Xiao B, Yang D, et al. RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). Proc Natl Acad Sci U S A. 2004;101(35):13062-13067.
Leybaert L, De Smet MA, Lissoni A, et al. Connexin hemichannels as candidate targets for cardioprotective and anti-arrhythmic treatments. J Clin Invest. 2023;133(6):e168117.
Wang N, De Vuyst E, Ponsaerts R, et al. Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury. Basic Res Cardiol. 2013;108(1):309.
Catarino S, Ramalho JS, Marques C, Pereira P, Girão H. Ubiquitin-mediated internalization of connexin43 is independent of the canonical endocytic tyrosine-sorting signal. Biochem J. 2011;437(2):255-267.
Wallraff A, Köhling R, Heinemann U, Theis M, Willecke K, Steinhäuser C. The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus. J Neurosci. 2006;26(20):5438-5447.
Sherwood MW, Arizono M, Panatier A, Mikoshiba K, Oliet SHR. Astrocytic IP(3)Rs: beyond IP(3)R2. Front Cell Neurosci. 2021;15:695817.
Sherwood MW, Arizono M, Hisatsune C, et al. Astrocytic IP(3) Rs: contribution to Ca(2+) signalling and hippocampal LTP. Glia. 2017;65(3):502-513.
Takano T, Wallace JT, Baldwin KT, et al. Chemico-genetic discovery of astrocytic control of inhibition in vivo. Nature. 2020;588(7837):296-302.
De Vuyst E, Decrock E, Cabooter L, et al. Intracellular calcium changes trigger connexin 32 hemichannel opening. EMBO J. 2006;25(1):34-44.
De Vuyst E, Wang N, Decrock E, et al. Ca(2+) regulation of connexin 43 hemichannels in C6 glioma and glial cells. Cell Calcium. 2009;46(3):176-187.
Li H, Liu TF, Lazrak A, et al. Properties and regulation of gap junctional hemichannels in the plasma membranes of cultured cells. J Cell Biol. 1996;134(4):1019-1030.
Contreras JE, Sáez JC, Bukauskas FF, Bennett MVL. Gating and regulation of connexin 43 (Cx43) hemichannels. Proc Natl Acad Sci U S A. 2003;100(20):11388-11393.
Thimm J, Mechler A, Lin H, Rhee S, Lal R. Calcium-dependent open/closed conformations and interfacial energy maps of reconstituted hemichannels. J Biol Chem. 2005;280(11):10646-10654.
Saleem H, Tovey SC, Molinski TF, Taylor CW. Interactions of antagonists with subtypes of inositol 1,4,5-trisphosphate (IP3) receptor. Br J Pharmacol. 2014;171(13):3298-3312.
Bai D, del Corsso C, Srinivas M, Spray DC. Block of specific gap junction channel subtypes by 2-aminoethoxydiphenyl borate (2-APB). J Pharmacol Exp Ther. 2006;319(3):1452-1458.
Wang N, De Bock M, Decrock E, et al. Paracrine signaling through plasma membrane hemichannels. Biochim Biophys Acta. 2013;1828(1):35-50.
Abudara V, Bechberger J, Freitas-Andrade M, et al. The connexin43 mimetic peptide Gap19 inhibits hemichannels without altering gap junctional communication in astrocytes. Front Cell Neurosci. 2014;8:306.
Giaume C, Naus CC, Sáez JC, Leybaert L. Glial connexins and pannexins in the healthy and diseased brain. Physiol Rev. 2021;101(1):93-145.
Srinivasan R, Huang BS, Venugopal S, et al. Ca(2+) signaling in astrocytes from Ip3r2(−/−) mice in brain slices and during startle responses in vivo. Nat Neurosci. 2015;18(5):708-717.
Okubo Y, Kanemaru K, Suzuki J, Kobayashi K, Hirose K, Iino M. Inositol 1,4,5-trisphosphate receptor type 2-independent Ca(2+) release from the endoplasmic reticulum in astrocytes. Glia. 2019;67(1):113-124.
Okubo Y, Iino M. Visualization of astrocytic intracellular Ca(2+) mobilization. J Physiol. 2020;598(9):1671-1681.
Golovina VA, Blaustein MP. Spatially and functionally distinct Ca2+ stores in sarcoplasmic and endoplasmic reticulum. Science. 1997;275(5306):1643-1648.
De Bock M, De Smet M, Verwaerde S, et al. Targeting gliovascular connexins prevents inflammatory blood-brain barrier leakage and astrogliosis. JCI Insight. 2022;7(16):e135263.
Betzenhauser MJ, Wagner LE 2nd, Iwai M, Michikawa T, Mikoshiba K, Yule DI. ATP modulation of Ca2+ release by type-2 and type-3 inositol (1, 4, 5)-triphosphate receptors. Differing ATP sensitivities and molecular determinants of action. J Biol Chem. 2008;283(31):21579-21587.
Chandrasekhar R, Alzayady KJ, Wagner LE 2nd, Yule DI. Unique regulatory properties of heterotetrameric inositol 1,4,5-trisphosphate receptors revealed by studying concatenated receptor constructs. J Biol Chem. 2016;291(10):4846-4860.
Le HT, Sin WC, Lozinsky S, et al. Gap junction intercellular communication mediated by connexin43 in astrocytes is essential for their resistance to oxidative stress. J Biol Chem. 2014;289(3):1345-1354.
Schildge S, Bohrer C, Beck K, Schachtrup C. Isolation and culture of mouse cortical astrocytes. J Vis Exp. 2013;71:50079.
Fan G, Baker MR, Wang Z, et al. Cryo-EM reveals ligand induced allostery underlying InsP(3)R channel gating. Cell Res. 2018;28(12):1158-1170.
Betzenhauser MJ, Wagner LE 2nd, Park HS, Yule DI. ATP regulation of type-1 inositol 1,4,5-trisphosphate receptor activity does not require walker A-type ATP-binding motifs. J Biol Chem. 2009;284(24):16156-16163.
Monaco G, Decrock E, Akl H, et al. Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-xl. Cell Death Differ. 2012;19(2):295-309.
Sipma H, De Smet P, Sienaert I, et al. Modulation of inositol 1,4,5-trisphosphate binding to the recombinant ligand-binding site of the type-1 inositol 1,4,5-trisphosphate receptor by Ca2+ and calmodulin. J Biol Chem. 1999;274(17):12157-12162.
Parys JB, de Smedt H, Missiaen L, Bootman MD, Sienaert I, Casteels R. Rat basophilic leukemia cells as model system for inositol 1,4,5-trisphosphate receptor IV, a receptor of the type II family: functional comparison and immunological detection. Cell Calcium. 1995;17(4):239-249.
Ivanova H, Ritaine A, Wagner L, et al. The trans-membrane domain of Bcl-2α, but not its hydrophobic cleft, is a critical determinant for efficient IP3 receptor inhibition. Oncotarget. 2016;7(34):55704-55720.
Lazic SE, Clarke-Williams CJ, Munafò MR. What exactly is ‘N’ in cell culture and animal experiments? PLoS Biol. 2018;16(4):e2005282.
Zissimopoulos S, Seifan S, Maxwell C, Williams AJ, Lai FA. Disparities in the association of the ryanodine receptor and the FK506-binding proteins in mammalian heart. J Cell Sci. 2012;125(Pt 7):1759-1769.
Li J, Imtiaz MS, Beard NA, et al. ß-adrenergic stimulation increases RyR2 activity via intracellular Ca2+ and Mg2+ regulation. PLoS ONE. 2013;8(3):e58334.